Application of Stereotactic Body Radiation Therapy in the Local Treatment of Primary Renal Cell Carcinoma: A Review

Authors

  • Junming Zhu Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • Xinyi Cao Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • Hongbin Deng Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Keywords:

stereotactic body radiation therapy, primary renal cell carcinoma, non-surgical treatment

Abstract

Renal cell carcinoma (RCC) is one of the most common malignant tumors of the urinary system in adults, with its incidence steadily increasing, posing a significant threat to the health of elderly patients. Surgery remains the standard treatment for primary RCC; however, surgical intervention is often limited in elderly patients due to the frequent presence of multiple comorbidities. In recent years, stereotactic body radiation therapy (SBRT), with its high dose per fraction, high precision, and non-invasive nature, has been widely used for local management of primary RCC. This article reviews the application and related research of SBRT in the local treatment of primary RCC.

Downloads

Published

2025-03-31

Issue

Vol. 4 No. 2 (2025): March

Section

Articles